1. |
Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health, 2018, 6(5): e555-e567.
|
2. |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin, 2018, 68(1): 7-30.
|
3. |
International Agency for Research on Cancer, World Health Organization. Global cancer observatory 2018. http://gco.iarc.fr/.
|
4. |
Wong MCS, Jiang JY, Liang M, et al. Global temporal patterns of pancreatic cancer and association with socioeconomic development. Sci Rep, 2017, 7(1): 3165.
|
5. |
Schmohl KA, Gupta A, Grünwald GK, et al. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene. Oncotarget, 2017, 8(20): 33393-33404.
|
6. |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386.
|
7. |
Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res, 2014, 74(11): 2913-2921.
|
8. |
Midha S, Chawla S, Garg PK. Modifiable and non-modifiable risk factors for pancreatic cancer: a review. Cancer Lett, 2016, 381(1): 269-277.
|
9. |
Wolpin BM, Chan AT, Hartge P, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 2009, 101(6): 424-431.
|
10. |
Wolpin BM, Kraft P, Gross M, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res, 2010, 70(3): 1015-1023.
|
11. |
Becker AE, Hernandez YG, Frucht H, et al. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol, 2014, 20(32): 11182-11198.
|
12. |
王方华, 吴怡林, 龚建平. KRAS突变与胰腺癌的发生及治疗的研究进展. 中国普外基础与临床杂志, 2019, 26(6): 764-768.
|
13. |
Riegert-Johnson DL, Westra W, Roberts M. High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut, 2012, 61(2): 322.
|
14. |
Bosetti C, Lucenteforte E, Silverman DT, et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol, 2012, 23(7): 1880-1888.
|
15. |
Allen NE, Beral V, Casabonne D, et al. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst, 2009, 101(5): 296-305.
|
16. |
Zheng W, McLaughlin JK, Gridley G, et al. A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control, 1993, 4(5): 477-482.
|
17. |
Harnack LJ, Anderson KE, Zheng W, et al. Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev, 1997, 6(12): 1081-1086.
|
18. |
Heuch I, Kvåle G, Jacobsen BK, et al. Use of alcohol, tobacco and coffee, and risk of pancreatic cancer. Br J Cancer, 1983, 48(5): 637-643.
|
19. |
Silverman DT, Brown LM, Hoover RN, et al. Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res, 1995, 55(21): 4899-4905.
|
20. |
Partanen TJ, Vainio HU, Ojajärvi IA, et al. Pancreas cancer, tobacco smoking and consumption of alcoholic beverages: a case-control study. Cancer Lett, 1997, 116(1): 27-32.
|
21. |
Suzuki T, Matsuo K, Sawaki A, et al. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev, 2008, 17(10): 2742-2747.
|
22. |
Jiao L, Silverman DT, Schairer C, et al. Alcohol use and risk of pancreatic cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol, 2009, 169(9): 1043-1051.
|
23. |
Michaud DS, Vrieling A, Jiao L, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control, 2010, 21(8): 1213-1225.
|
24. |
Wang YT, Gou YW, Jin WW, et al. Association between alcohol intake and the risk of pancreatic cancer: a dose-response meta-analysis of cohort studies. BMC Cancer, 2016, 16: 212.
|
25. |
WCRFI. Pancreatic cancer statistics. World cancer research fund international. 2015. http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/pancreatic-cancerstatistics.
|
26. |
Davoodi SH, Malek-Shahabi T, Malekshahi-Moghadam A, et al. Obesity as an important risk factor for certain types of cancer. Iran J Cancer Prev, 2013, 6(4): 186-194.
|
27. |
Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol, 2015, 44(1): 186-198.
|
28. |
Paluszkiewicz P, Smolińska K, Dębińska I, et al. Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case-control and cohort studies. Cancer Epidemiol, 2012, 36(1): 60-67.
|
29. |
Bao Y, Hu FB, Giovannucci EL, et al. Nut consumption and risk of pancreatic cancer in women. Br J Cancer, 2013, 109(11): 2911-2916.
|
30. |
Wu L, Wang Z, Zhu J, et al. Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis. Nutr Rev, 2015, 73(7): 409-425.
|
31. |
Appleby PN, Crowe FL, Bradbury KE, et al. Mortality in vegetarians and comparable nonvegetarians in the United Kingdom. Am J Clin Nutr, 2016, 103(1): 218-230.
|
32. |
Lightsey D, National Council Against Health Fraud and Quackwatch. Comment on ‘Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies’. Br J Cancer, 2012, 107(4): 754-755.
|
33. |
Beaney AJ, Banim PJR, Luben R, et al. Higher meat intake is positively associated with higher risk of developing pancreatic cancer in an age-dependent manner and are modified by plasma antioxidants: a prospective cohort study (EPIC-Norfolk) using data from food diaries. Pancreas, 2017, 46(5): 672-678.
|
34. |
Miller PE, Alexander D. A review and meta-analysis of prospective studies of red and processed meat and pancreatic cancer. FASEB J, 2016, 30: 902-909.
|
35. |
Yorifuji T, Tsuda T, Doi H, et al. Cancer excess after arsenic exposure from contaminated milk powder. Environ Health Prev Med, 2011, 16(3): 164-170.
|
36. |
Yorifuji T, Tsuda T, Grandjean P. Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder. J Natl Cancer Inst, 2010, 102(5): 360-361.
|
37. |
Burney PG, Comstock GW, Morris JS. Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr, 1989, 49(5): 895-900.
|
38. |
Stevens RJ, Roddam AW, Beral V. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer, 2007, 96(3): 507-509.
|
39. |
Huxley R, Ansary-Moghaddam A, Berrington de González A, et al. Type-Ⅱ diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer, 2005, 92(11): 2076-2083.
|
40. |
Li D, Tang H, Hassan MM, et al. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control, 2011, 22(2): 189-197.
|
41. |
Bosetti C, Rosato V, Li D, et al. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Ann Oncol, 2014, 25(10): 2065-2072.
|
42. |
Sharma A, Smyrk TC, Levy MJ, et al. Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis. Gastroenterology, 2018, 155(2): 490-500.
|
43. |
Grote VA, Rohrmann S, Nieters A, et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia, 2011, 54(12): 3037-3046.
|
44. |
Midha S, Sreenivas V, Kabra M, et al. Genetically determined chronic pancreatitis but not alcoholic pancreatitis is a strong risk factor for pancreatic cancer. Pancreas, 2016, 45(10): 1478-1484.
|
45. |
Raimondi S, Lowenfels AB, Morselli-Labate AM, et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol, 2010, 24(3): 349-358.
|
46. |
Fan X, Alekseyenko AV, Wu J, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut, 2018, 67(1): 120-127.
|
47. |
Memba R, Duggan SN, Ni Chonchubhair HM, et al. The potential role of gut microbiota in pancreatic disease: a systematic review. Pancreatology, 2017, 17(6): 867-874.
|
48. |
Guo Y, Liu W, Wu J. Helicobacter pylori infection and pancreatic cancer risk: a meta-analysis. J Cancer Res Ther, 2016, 12(Supplement): C229-C232.
|
49. |
曹成亮, 曲凤智, 王刚, 等. 幽门螺杆菌在胰腺癌发生发展中作用的研究进展. 中国普外基础与临床杂志, 2017, 24(10): 1275-1278.
|